Top 10 Undervalued Stocks To Watch For 2019

Major market benchmarks fell in Tuesday’s shortened session ahead of the July 4 holiday, giving back earlier gains as investors weighed the effects of a potential trade war, with new tariffs to be imposed on Chinese products later this week.

But some individual stocks easily outperformed the rest. Read on to learn what had Campbells Soup Company (NYSE:CPB), Veon (NASDAQ:VEON), and AZZ (NYSE:AZZ) climbing higher today.

Image source: Getty Images.

This investor wants Campbell Soup to sell

Shares of Campbell Soup climbed 1.9% after The New York Post reported that activist investor Dan Loeb is planning a “major shakeup” at the company with the help of large stakeholders. 

Arguing that Campbell Soup stock is undervalued, Loeb’s Third Point hedge fund is conversing with family members, who control roughly 41% of Campbell’s total shares, as well as other independent investors to encourage Campbell Soup to hire a bank to explore a possible sale of the company. For perspective, last month Campbell announced a broader strategic review of its plans and product portfolio. Now, however, The Post says Loeb is requesting that Campbell Soup abandon all other alternatives to focus exclusively on a sale. 

Top 10 Undervalued Stocks To Watch For 2019: NeuroMetrix Inc.(NURO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Haemonetics (NYSE: HAE) and Neurometrix (NASDAQ:NURO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

  • [By Logan Wallace]

    Obalon Therapeutics (NASDAQ: OBLN) and Neurometrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.

Top 10 Undervalued Stocks To Watch For 2019: EOG Resources, Inc.(EOG)

Advisors’ Opinion:

  • [By Logan Wallace]

    Beese Fulmer Investment Management Inc. boosted its holdings in shares of EOG Resources Inc (NYSE:EOG) by 1.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 53,371 shares of the energy exploration company’s stock after purchasing an additional 861 shares during the period. EOG Resources makes up 1.3% of Beese Fulmer Investment Management Inc.’s investment portfolio, making the stock its 24th largest holding. Beese Fulmer Investment Management Inc.’s holdings in EOG Resources were worth $6,809,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Investors sold shares of EOG Resources (NYSE:EOG) on strength during trading hours on Thursday. $133.11 million flowed into the stock on the tick-up and $162.08 million flowed out of the stock on the tick-down, for a money net flow of $28.97 million out of the stock. Of all companies tracked, EOG Resources had the 14th highest net out-flow for the day. EOG Resources traded up $4.65 for the day and closed at $126.15

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to today’s report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.3% to $80.59, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 0.3%, at $4.52 in a 52-week range of $2.53 to $5.60. EOG Resources Inc. (NYSE: EOG) traded up about 0.3% to $119.12. The 52-week range is $83.61 to $131.60.

    The United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.3%, at $23.47 in a 52-week range of $20.40 to $27.92.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.2%, at $85.99 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 0.7%, at $4.70 in a 52-week range of $2.53 to $5.60. EOG Resources Inc. (NYSE: EOG) traded down about 0.3% to $129.99. The 52-week range is $95.36 to $131.60.

    Meanwhile, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 2%, at $26.32 in a 52-week range of $20.40 to $27.43.

Top 10 Undervalued Stocks To Watch For 2019: Northgate Minerals Corporation(NXG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Top 10 Undervalued Stocks To Watch For 2019: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Investors are beginning to wonder if bluebird bio is at risk of losing market share before it really even begins life as a commercial company. The latest example: In September Amgen (NASDAQ:AMGN) released promising preliminary data from a small ongoing phase 1 trial, investigating a new immunotherapy as a potential treatment for advanced multiple myeloma. While the initial data release included just five patients, all had failed to respond to between four and six previous treatments. Amgen’s drug, AMG-420, a “simpler” immunotherapy compared to the cellular therapies being developed by bluebird bio and Celgene, resulted in a complete remission in four of them. That’s very impressive.

  • [By Max Byerly]

    Gables Capital Management Inc. purchased a new stake in Amgen, Inc. (NASDAQ:AMGN) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,023 shares of the medical research company’s stock, valued at approximately $174,000.

  • [By Keith Speights]

    That difficulty hasn’t stopped market research firm EvaluatePharma from trying, though. EvaluatePharma recently published a list of the drugmakers with the projected highest value creation from pipeline products between 2018 and 2024. Here’s why Novartis (NYSE:NVS), AbbVie (NYSE:ABBV), Celgene (NASDAQ:CELG), AstraZeneca (NYSE:AZN), and Amgen (NASDAQ:AMGN) ranked at the top.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Amgen (NASDAQ:AMGN), and Johnson & Johnson (NYSE:JNJ) rank as the three top biopharmaceutical companies when it comes to cash stockpiles. Here’s what these drugmakers are most likely to do with all that money — and whether or not you should consider investing some of your hard-earned cash to buy their stocks.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.62 million shares from the previous level of 9.79 million. Shares were last seen at $178.26, in a 52-week trading range of $153.56 to $201.23.

  • [By Cory Renauer]

    Lilly investors can also look forward to growing sales of the third new treatment for the prevention of migraine headaches. Emgality launched in October months after competing treatments from Amgen (NASDAQ:AMGN) and Teva Pharmaceuticals (NYSE:TEVA) late last year.

Top 10 Undervalued Stocks To Watch For 2019: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in Celestica Inc (NYSE:CLS) (TSE:CLS) by 18.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,492,435 shares of the technology company’s stock after selling 343,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 1.20% of Celestica worth $19,894,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Celestica alerts:

    Global White Box Server Market Trend 2018- Quanta, Wistron, Inventec, Hon Hai, MiTAC, Celestica, Super Micro … (nwctrail.com) Taking Aim at Celestica Inc (CLS) Shares (parkcitycaller.com) When to Buy Opportunity? Celestica Inc. (CLS) (nysestocks.review) Electronic Manufacturing Services (EMS) Market 2018: Global Analysis by Key Players – Foxconn, Flextronics, Celestica (industrytoday.co.uk) Riveting Stock Watch: Celestica Inc. (TSX:CLS) Earnings Growth in the Spotlight (derbynewsjournal.com)

    A number of equities research analysts have recently issued reports on the company. TheStreet upgraded Celestica from a “c+” rating to a “b-” rating in a research note on Monday, May 7th. Zacks Investment Research cut Celestica from a “hold” rating to a “sell” rating in a research note on Thursday, May 3rd. Royal Bank of Canada upped their price objective on Celestica from $11.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Monday, April 30th. Finally, Beacon Securities reiterated a “buy” rating on shares of Celestica in a research note on Monday, January 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $13.27.

  • [By Evan Niu, CFA]

    Shares of Celestica (NYSE:CLS) have plunged today, down by 16% as of 10:45 a.m. EST, after the company reported fourth-quarter earnings results. The electronics manufacturing specialist missed earnings estimates and forecast first-quarter earnings below expectations as well.

Top 10 Undervalued Stocks To Watch For 2019: One Liberty Properties Inc.(OLP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) declared a quarterly dividend on Friday, September 14th, Wall Street Journal reports. Shareholders of record on Tuesday, September 25th will be paid a dividend of 0.45 per share by the real estate investment trust on Thursday, October 4th. This represents a $1.80 annualized dividend and a yield of 6.36%. The ex-dividend date is Monday, September 24th.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) VP Justin Clair sold 3,100 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $25.00, for a total value of $77,500.00. Following the completion of the transaction, the vice president now directly owns 32,566 shares in the company, valued at $814,150. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Watch For 2019: OncoSec Medical Incorporated(ONCS)

Advisors’ Opinion:

  • [By Max Byerly]

    OncoSec Medical Inc (NASDAQ:ONCS) traded up 5.9% on Wednesday . The stock traded as high as $1.45 and last traded at $1.43. 506,563 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 730,660 shares. The stock had previously closed at $1.35.

  • [By Logan Wallace]

    Here are some of the headlines that may have effected Accern Sentiment’s rankings:

    Get OncoSec Medical alerts:

    OncoSec Medical (ONCS) Given Buy Rating at Dawson James (americanbankingnews.com) OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer (finance.yahoo.com) OncoSec appoints Sara M. Bonstein as CFO and COO (seekingalpha.com) Oncosec Medical (ONCS) Appoints Sara M. Bonstein as CFO and COO (streetinsider.com) OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer (finance.yahoo.com)

    ONCS stock traded down $0.02 during trading on Thursday, reaching $1.28. The company’s stock had a trading volume of 367,800 shares, compared to its average volume of 916,959. OncoSec Medical has a 1 year low of $0.88 and a 1 year high of $2.95. The firm has a market capitalization of $68.05 million, a PE ratio of -1.21 and a beta of 2.98.

  • [By Stephan Byrd]

    HC Wainwright set a $4.00 price target on OncoSec Medical (NASDAQ:ONCS) in a research report released on Tuesday. The firm currently has a buy rating on the biotechnology company’s stock.

Top 10 Undervalued Stocks To Watch For 2019: CBRE Group, Inc.(CBG)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Ethan Ryder]

    Peel Hunt reaffirmed their hold rating on shares of Close Brothers Group (LON:CBG) in a report issued on Tuesday.

    Several other equities research analysts also recently issued reports on CBG. Shore Capital reiterated a hold rating on shares of Close Brothers Group in a report on Wednesday, July 18th. Numis Securities upgraded Close Brothers Group to an add rating in a report on Wednesday, July 18th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of GBX 1,561.30 ($20.34).

Top 10 Undervalued Stocks To Watch For 2019: SharpSpring, Inc.(SHSP)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

Top 10 Undervalued Stocks To Watch For 2019: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of skincare pharmaceutical specialist Dermira (NASDAQ:DERM) dropped nearly 23% today after the company hosted its investor and analyst day for 2018. Investors were none too thrilled with the presentations given — and were only reminded about the stinging failure of a once-promising acne drug DRM01 in March. Shares slipped over 64% on that news.

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By Shane Hupp]

    Dermira (NASDAQ:DERM) has been given a $20.00 price target by Cantor Fitzgerald in a research note issued to investors on Thursday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 146.61% from the company’s previous close. Cantor Fitzgerald also issued estimates for Dermira’s FY2018 earnings at ($4.63) EPS.

Leave a Reply

Your email address will not be published. Required fields are marked *